EUVIMEDEUVIMED entdecken
Crossref

Nose-to-brain delivery of quercetin-loaded chitosan nanoparticles improves post-traumatic stress disorder-like phenotypes in mice

Mohd Rabi Bazaz, Padakanti Sandeep Chary, Sandeep Guin, Neelesh Kumar Mehra, Manoj P Dandekar

European Journal of Pharmacology · 2026

DOI: 10.1016/j.ejphar.2025.178477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Mohd Rabi Bazaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, 50003…. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Chitosan, Quercetin, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-traumatic stress disorder (PTSD) is a stressful mental illness that arises after exposure to unforeseen traumatic events. The majority of PTSD cases are often refractory to pharmacological interventions. Herein, considering the neuroprotective effects of quercetin and chitosan in several brain disorders, we examined the effect of quercetin-loaded chitosan nanoparticles (QCNPs), administered via nose-to-brain delivery, on PTSD-like phenotypes in mice. QCNPs were synthesized using the ethanol injection method. We observed uniform spherical structure and 120-170 nm diameter of nanoparticles in transmission-electron microscopy analysis. The polydispersity index, zeta potential, and entrapment efficiency were 0.36 ± 0.0104, 39.05 mV, and 81.86 ± 1.60 %, respectively. Male C57BL/6 mice subjected to controlled-cortical impact (CCI) surgery followed by single-prolonged stress (SPS) exhibited PTSD-like symptoms, including deficits in sociability, anxiety and cognition. The CCI + SPS-driven neurobehavioral dysfunctions related to sociability index, anxiety-like phenotype, and cognition were evaluated employing social-approach social avoidance (SASA), elevated zero maze (EZM), Y-maze, and novel object recognition task (NORT). Intranasal delivery of QCNPs, at 0.06 mg/kg of body weight for 14 days, ameliorated CCI + SPS-generated PTSD-like behaviors in mice. The depleted levels of postsynaptic-density protein 95 (PSD-95), brain-derived neurotrophic factor (BDNF), and doublecortin in the hippocampus of CCI + SPS-exposed mice were restored following QCNPs treatment. Moreover, QCNPs administration reduced the expression of astrocyte marker glial-fibrillary acidic protein (GFAP), IBA-1, c-Fos, and proinflammatory cytokines (C-reactive protein, IL-6, TNF-α, and IL-1β) in the hippocampus of CCI + SPS group. These results suggest that nose-to-brain delivery of QCNPs reverses CCI + SPS-generated PTSD-like phenotypes by modulating neuroinflammatory mediators and enhancing neuronal and synaptic proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticChitosanQuercetinNanoparticlesBrainNeuroprotective AgentsAnimalsMaleAdministration, IntranasalMiceMice, Inbred C57BLPhenotypeBehavior, AnimalDoublecortin ProteinBrain-Derived Neurotrophic FactorDisease Models, AnimalHippocampus

Stichwörter der Autor:innen

ChitosanControlled-cortical impactNose-to-brain deliveryPTSDQuercetinSPSTBI

Substanzen

ChitosanQuercetinDoublecortin ProteinDcx protein, mouseNeuroprotective AgentsBrain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, 500037, India.
  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, 500037, India.
  • Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, 500037, India. Electronic address: manoj.dandekar@niperhyd.ac.in.

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Bazaz, M. R., Chary, P. S., Guin, S., Mehra, N. K., & Dandekar, M. P. (2026). Nose-to-brain delivery of quercetin-loaded chitosan nanoparticles improves post-traumatic stress disorder-like phenotypes in mice. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178477

Vancouver

Bazaz MR, Chary PS, Guin S, Mehra NK, Dandekar MP. Nose-to-brain delivery of quercetin-loaded chitosan nanoparticles improves post-traumatic stress disorder-like phenotypes in mice. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178477

BibTeX
@article{Bazaz2026,
  author = {Bazaz, Mohd Rabi and Chary, Padakanti Sandeep and Guin, Sandeep and Mehra, Neelesh Kumar and Dandekar, Manoj P},
  title = {Nose-to-brain delivery of quercetin-loaded chitosan nanoparticles improves post-traumatic stress disorder-like phenotypes in mice},
  journal = {European Journal of Pharmacology},
  year = {2026},
  doi = {10.1016/j.ejphar.2025.178477}
}
Kostenlos starten →